CENPF knockdown inhibits adriamycin chemoresistance in triple-negative breast cancer via the Rb-E2F1 axis
Open Access
- 31 January 2023
- journal article
- research article
- Published by Springer Nature in Scientific Reports
- Vol. 13 (1) , 1-10
Abstract
Drug resistance occurs frequently in triple-negative breast cancer (TNBC) and leads to early relapse and short survival. Targeting the DNA damage response (DDR) has become an effective strategy for overcoming TNBC chemoresistance. CENPF (centromere protein) is a key regulator of cell cycle progression, but its role in TNBC chemotherapy resistance remains unclear. Here, we found that CENPF, which is highly expressed in TNBC, is associated with a poor prognosis in patients receiving chemotherapy. In addition, in vitro CENPF knockdown significantly increased adriamycin (ADR)-induced cytotoxicity in MDA-MB-231 cells and ADR-resistant cells (MDA-MB-231/ADR). Then, we demonstrated that CENPF targets Chk1-mediated G2/M phase arrest and binds to Rb to compete with E2F1 in TNBC. Considering the crucial role of E2F1 in the DNA damage response and DNA repair, a novel mechanism by which CENPF regulates the Rb-E2F1 axis will provide new horizons to overcome chemotherapy resistance in TNBC.Keywords
All Related Versions
Funding Information
- National Natural Science Foundation of China (81671605, 81572594)
- Natural Science Foundation of Shandong Province (ZR2022MH038)
This publication has 40 references indexed in Scilit:
- E2F1 apoptosis counterattacked: evil strikes backTrends in Molecular Medicine, 2013
- Molecular definitions of cell death subroutines: recommendations of the Nomenclature Committee on Cell Death 2012Cell Death & Differentiation, 2011
- Prognostic significance and therapeutic implications of centromere protein F expression in human nasopharyngeal carcinomaMolecular Cancer, 2010
- What is triple-negative breast cancer?European Journal of Cancer, 2008
- The E2F-Regulated Gene Chk1 Is Highly Expressed in Triple-Negative Estrogen Receptor−/Progesterone Receptor−/HER-2− Breast CarcinomasCancer Research, 2007
- CENP‐F expression is associated with poor prognosis and chromosomal instability in patients with primary breast cancerInternational Journal of Cancer, 2007
- Mitosin/CENP-F in mitosis, transcriptional control, and differentiationJournal of Biomedical Science, 2006
- The cell-cycle checkpoint kinase Chk1 is required for mammalian homologous recombination repairNature Cell Biology, 2005
- CENP-F is a protein of the nuclear matrix that assembles onto kinetochores at late G2 and is rapidly degraded after mitosis.Journal of Cell Biology, 1995
- CENP‐F is a ca 400 kDa kinetochore protein that exhibits a cell‐cycle dependent localizationCell Motility, 1993